Literature DB >> 31514983

A hepatoprotection study of Radix Bupleuri on acetaminophen-induced liver injury based on CYP450 inhibition.

Yu-Xin Wang1, Yi DU2, Xia-Fei Liu2, Fang-Xiu Yang2, Xiao Wu2, Li Tan3, Yi-Hong Lu4, Jing-Wei Zhang5, Fang Zhou5, Guang-Ji Wang6.   

Abstract

We investigated the potential hepatoprotective effect of Radix Bupleuri (RB) by inducing acute liver injury (ALI) in an animal model using acetaminophen (APAP) after pretreatment with RB aqueous extract for three consecutive days. Compared to those of the APAP group, the biochemical and histological results of the RB pretreatment group showed lower serumaspartate transaminase (AST) and alanine transaminase (ALT) levels as well as less liver damage. Pharmacokinetic study of the toxicity related marker acetaminophen-cysteine (APC) revealed a lower exposure level in rats, suggesting that RB alleviated APAP-induced liver damage by preventing glutathione (GSH) depletion. The results of cocktail approach showed significant inhibition of CYP2E1 and CYP3A activity. Further investigation revealed the increasing of CYP2E1 and CYP3A protein was significantly inhibited in pretreatment group, while no obvious effect on gene expression was found. Therefore, this study clearly demonstrates that RB exhibited significant protective action against APAP-induced acute live injury via pretreatment, and which is partly through inhibiting the increase of activity and translation of cytochrome P450 enzymes, rather than gene transcription.
Copyright © 2019 China Pharmaceutical University. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Acetaminophen; Acute liver injury; Cytochrome P450 enzymes; Hepatoprotection; Radix Bupleuri

Mesh:

Substances:

Year:  2019        PMID: 31514983     DOI: 10.1016/S1875-5364(19)30073-1

Source DB:  PubMed          Journal:  Chin J Nat Med        ISSN: 1875-5364


  6 in total

1.  Fulminant hepatorenal syndrome due to Acetaminophen toxicity: A case report.

Authors:  Zahra Nekoukar; Minoo Moghimi; Zakaria Zakariaei; Mahdi Fakhar; Rabeeh Tabaripour
Journal:  Clin Case Rep       Date:  2021-03-24

2.  Integrative lipidomic and transcriptomic study unravels the therapeutic effects of saikosaponins A and D on non-alcoholic fatty liver disease.

Authors:  Xiaojiaoyang Li; Junde Ge; Yajing Li; Yajie Cai; Qi Zheng; Nana Huang; Yiqing Gu; Qi Han; Yunqian Li; Rong Sun; Runping Liu
Journal:  Acta Pharm Sin B       Date:  2021-03-11       Impact factor: 11.413

3.  Validation of the Anticolitis Efficacy of the Jian-Wei-Yu-Yang Formula.

Authors:  Jing Yan; Yan Tang; Wei Yu; Lu Jiang; Chen Liu; Qi Li; Zhiqiang Zhang; Changlei Shao; Yang Zheng; Xihao Liu; Xincheng Liu
Journal:  Evid Based Complement Alternat Med       Date:  2022-08-31       Impact factor: 2.650

4.  Comprehensive comparison on the anti-inflammation and GC-MS-based metabolomics discrimination between Bupleuri chinense DC. and B. scorzonerifolium Willd.

Authors:  Mingming Zhao; Linxuan Xiao; Ke-Gang Linghu; Guanding Zhao; Qiling Chen; Liyu Shen; Parsa Dar; Meiwan Chen; Yuan Hu; Jinming Zhang; Hua Yu
Journal:  Front Pharmacol       Date:  2022-09-14       Impact factor: 5.988

5.  Response of soil microecology to different cropping practice under Bupleurum chinense cultivation.

Authors:  Li Liu; Hailu Cao; Yannan Geng; Quanfang Zhang; Xun Bu; Demin Gao
Journal:  BMC Microbiol       Date:  2022-09-22       Impact factor: 4.465

6.  Network Pharmacological Analysis and Experimental Validation of the Mechanisms of Action of Si-Ni-San Against Liver Fibrosis.

Authors:  Siliang Wang; Cheng Tang; Heng Zhao; Peiliang Shen; Chao Lin; Yun Zhu; Dan Han
Journal:  Front Pharmacol       Date:  2021-07-01       Impact factor: 5.810

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.